A Hemorrhagic Clival Chordoma with a Long Progression-Free Survival

被引:7
作者
Vilela, Marcelo D. [1 ,2 ]
Pedrosa, Hugo A. S. [1 ]
Dias Filho, Marco Antonio [3 ]
机构
[1] Mater Dei Hosp, Dept Neurosurg, Belo Horizonte, MG, Brazil
[2] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA
[3] Lab Anat & Patol Diagnost, Belo Horizonte, MG, Brazil
关键词
Chordoma; Ecchordosis physaliphora; Hemorrhage; ENDOTHELIAL GROWTH-FACTOR; ECCHORDOSIS-PHYSALIPHORA; INTRATUMORAL HEMORRHAGE; EXPRESSION; VEGF;
D O I
10.1016/j.wneu.2017.06.169
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: Chordomas and ecchordosis physaliphora may on rare occasions present with intracranial hemorrhage. Their distinction usually relies on the results of the Ki-67 proliferative index, with a result lower than 1% favoring ecchordosis physaliphora. Intracranial hemorrhagic chordomas have been linked to unfavorable prognosis, due to acute neurologic deterioration and death, or progression after treatment. To the best of our knowledge, this is the first report of a patient with an intracranial hemorrhagic chordoma who had a long progression-free survival. CASE DESCRIPTION: A 67-year-old woman presented with a large hemorrhagic clival tumor that was resected through an endonasal endoscopic approach. Physallipharous cells interspersed in a myxoid matrix, positivity for S-100, cytokeratin, and epithelial membrane antigen were found, along with an extremely low Ki-67 index. Imaging findings of bone erosion, a large size, and enhancement favored the diagnosis of chordoma. The patient received adjuvant stereotactic radiotherapy and has remained disease free after 4 years. CONCLUSIONS: Although hemorrhagic intracranial chordomas have been linked to unfavorable outcomes, our case demonstrates that they may have a low proliferative index, and a long progression-free survival may be seen.
引用
收藏
页码:1042.e1 / 1042.e4
页数:4
相关论文
共 50 条
[21]   Increased signal intensity in FLAIR sequences in the resection cavity can predict progression and progression-free survival in gliomas [J].
Sarbu, Nicolae ;
Oleaga, Laura ;
Valduvieco, Izaskun ;
Pujol, Teresa ;
Berenguer, Joan .
NEUROCIRUGIA, 2016, 27 (06) :269-276
[22]   Prediction of Survival and Progression-free Survival Using Machine Learning in Stage III Lung Cancer: A Pilot Study [J].
Yakar, Melek ;
Etiz, Durmus ;
Yilmaz, Senay ;
Celik, Ozer ;
Guntulu, A. K. ;
Metintas, Muzaffer .
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2021, 36 (04) :446-458
[23]   Multiple genetic variants predict the progression-free survival of bevacizumab plus chemotherapy in advanced ovarian cancer A retrospective study [J].
Gao, Jie ;
Li, Fang ;
Liu, Zihao ;
Huang, Mengli ;
Chen, Huoming ;
Liao, Guoqing ;
Meng, Jichang ;
Wang, Qing ;
Zhao, Hui ;
Li, Chenxi ;
Ji, Jing ;
Cai, Shangli ;
Du, Nan .
MEDICINE, 2021, 100 (35)
[24]   Long-term progression-free survival in non-small cell lung cancer patients: a spotlight on bevacizumab and its biosimilars [J].
Seiwerth, Fran ;
Bitar, Lela ;
Samarzija, Miroslav ;
Jakopovic, Marko .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (10) :1017-1024
[25]   High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma [J].
Miller, A. ;
Asmann, Y. ;
Cattaneo, L. ;
Braggio, E. ;
Keats, J. ;
Auclair, D. ;
Lonial, S. ;
Russell, S. J. ;
Stewart, A. K. .
BLOOD CANCER JOURNAL, 2017, 7 :e612-e612
[26]   HER4 and its cytoplasmic isoforms are associated with progression-free survival of malignant melanoma [J].
Nielsen, Trine O. ;
Poulsen, Steen S. ;
Journe, Fabrice ;
Ghanem, Ghanem ;
Sorensen, Boe S. .
MELANOMA RESEARCH, 2014, 24 (01) :88-91
[27]   Obstructive Sleep Apnea Worsens Progression-Free and Overall Survival in Human Metastatic Colorectal Carcinoma [J].
Lacedonia, Donato ;
Landriscina, Matteo ;
Scioscia, Giulia ;
Tondo, Pasquale ;
Caccavo, Incoronata ;
Bruno, Giuseppina ;
Giordano, Guido ;
Piscazzi, Annamaria ;
Foschino Barbaro, Maria Pia .
JOURNAL OF ONCOLOGY, 2021, 2021
[28]   Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer [J].
Quinn, Michael C. J. ;
McCue, Karen ;
Shi, Wei ;
Johnatty, Sharon E. ;
Beesley, Jonathan ;
Civitarese, Andrew ;
O'Mara, Tracy A. ;
Glubb, Dylan M. ;
Tyrer, Jonathan P. ;
Armasu, Sebastian M. ;
Ong, Jue-Sheng ;
Gharahkhani, Puya ;
Lu, Yi ;
Gao, Bo ;
Patch, Ann-Marie ;
Fasching, Peter A. ;
Beckmann, Matthias W. ;
Lambrechts, Diether ;
Vergote, Ignace ;
Edwards, Digna R. Velez ;
Beeghly-Fadiel, Alicia ;
Benitez, Javier ;
Garcia, Maria J. ;
Goodman, Marc T. ;
Doerk, Thilo ;
Duerst, Matthias ;
Modugno, Francesmary ;
Moysich, Kirsten ;
du Bois, Andreas ;
Pfisterer, Jacobus ;
Bauman, Klaus ;
Karlan, Beth Y. ;
Lester, Jenny ;
Cunningham, Julie M. ;
Larson, Melissa C. ;
McCauley, Bryan M. ;
Kjaer, Susanne K. ;
Jensen, Allan ;
Hogdall, Claus K. ;
Hogdall, Estrid ;
Schildkraut, Joellen M. ;
Riggan, Marjorie J. ;
Berchuck, Andrew ;
Cramer, Daniel W. ;
Terry, Kathryn L. ;
Bjorge, Line ;
Webb, Penelope M. ;
Friedlander, Michael ;
Pejovic, Tanja ;
Moffitt, Melissa .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (09) :1669-1680
[29]   Association of somatic DNA methylation variability with progression-free survival and toxicity in ovarian cancer patients [J].
Flanagan, J. M. ;
Wilhelm-Benartzi, C. S. ;
Metcalf, M. ;
Kaye, S. B. ;
Brown, R. .
ANNALS OF ONCOLOGY, 2013, 24 (11) :2813-2818
[30]   Pretreatment Vitamin D Deficiency Is Associated With Impaired Progression-Free and Overall Survival in Hodgkin Lymphoma [J].
Borchmann, Sven ;
Cirillo, Melita ;
Goergen, Helen ;
Meder, Lydia ;
Sasse, Stephanie ;
Kreissl, Stefanie ;
Broeckelmann, Paul Jan ;
von Tresckow, Bastian ;
Fuchs, Michael ;
Ullrich, Roland Tillmann ;
Engert, Andreas .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (36) :3528-+